USV launches “usema” to address India’s metabolic health burden
USV Private, an Indian multinational healthcare company and a leader in diabetes care, announced the launch of usema, in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
India’s Pharma giants race to launch Semaglutide, intensifying GLP-1 market competition
India’s leading pharma companies have simultaneously forayed into the semaglutide segment, marking a major shift in the country’s…
BIRAC fuels innovation with Rs. 4,200 crore funding across 15 lakh startups and entrepreneurs
Biotechnology Industry Research Assistance Council (BIRAC), a Public Sector Enterprise set up by the Department of Biotechnology…
Lupin Manufacturing Solutions announces expansion of manufacturing facility at Dabhasa
Lupin Manufacturing Solutions (LMS), a global CRDMO and subsidiary of global pharma major Lupin Limited (Lupin), today announced a…
Eris launches weekly shot of Semaglutide starting at ₹220 per shot
Eris Lifesciences, a leading Indian branded formulations company, today announced a breakthrough step in expanding access to…
Glenmark Pharmaceuticals USA launches authorised generic to Milnacipran Hydrochloride tablets
Glenmark Pharmaceuticals USA announces the launch of Milnacipran Hydrochloride tablets, 12.5 mg, 25 mg, 50 mg, and 100 mg.…
Zydus launches Aerolife Mini, to simplify inhaler use for asthma and COPD patients
Zydus Lifesciences, an innovation-led life-sciences company with an international presence, has launched Aerolife Mini, a…
Partners in progress: PPL 2026
PPL 2026 brought together India’s pharma packaging ecosystem to explore how collaboration, innovation, and technical expertise can…
Akums launches first-of-its-kind Lasmiditan dispersible tablets for rapid migraine care
Akums Drugs & Pharmaceuticals has announced the launch of the world’s first Lasmiditan dispersible tablets, marking an…
Zydus and Torrent Pharma sign licensing agreement to co-market innovative Semaglutide injection in…
Zydus Lifesciences, an innovation-led global life-sciences company and Torrent Pharma, a specialty-focused global pharmaceutical…
CPHI Middle East and BIO Middle East set to position Saudi Arabia as global life sciences hub
CPHI Middle East and BIO Middle East are set to position Saudi Arabia at the forefront of the global life sciences sector with…
Strides strengthens its Africa business with acquisition of multiple generic brands from Sandoz
Strides Pharma Science announced that its step‑down subsidiary, Strides Pharma International AG (SPIAG), has entered into…
India’s upcoming semaglutide boom: A turning point for GLP‑1 drugs, pricing and patient access
With semaglutide’s Indian patent set to expire on March 20, 2026, domestic drugmakers are preparing to enter the GLP‑1 market,…
AstraZeneca Pharma India receives CDSCO approval for Durvalumab for patients with uHCC
AstraZeneca Pharma India, a global, science-led biopharmaceutical company, announced that Central Drugs Standard Control…
Orchid Pharma to set up ₹600 crore India’s first fermentation-based 7-ACA facility
The foundation stone laying ceremony for Orchid Biopharma’s 7-ACA fermentation facility was held in Kathua, Jammu & Kashmir,…
Bharat Biotech celebrates three decades of scientific excellence and global vaccine leadership
Bharat Biotech celebrated 30 years of scientific innovation, public health impact, and its continued commitment to protecting…
Employment discrepancies in pharma hiring stand at 12.1%: AuthBridge Workforce Fraud Files Report
India’s pharmaceutical sector continues to encounter significant hiring-related risks, particularly involving misrepresentation of…
Lupin and Zydus sign licensing agreement for co-marketing innovative Semaglutide injection in India
Global pharma major Lupin has entered into a Licensing and Supply Agreement with Zydus Lifesciences, an innovation-led…
HiMedia Laboratories honored with GS1 India 2026 Excellence Award for innovation in supply chain
HiMedia Laboratories, a global leader in biosciences, has been honored with the prestigious “GS1 India Excellence Award 2026” at…
Glenmark Pharmaceuticals USA to launch Potassium Phosphates injection USP
Glenmark Pharmaceuticals USA has announced the upcoming launch of Potassium Phosphates Injection USP, 15 mmol P / 22 mEq K per 5…